Pfizer Inc

Investment Portfolio & 13F Holdings Analysis

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-13
Total Holdings
21
Total Value
494849864
Accession Number
0000078003-25-000118
Form Type
13F-HR
Manager Name
Pfizer Inc
Data Enrichment
100% identified
21 identified0 unidentified

Holdings

21 positions
Manager:
Search and click to pin securities to the top
Page 1 of 2
BioNTech SE
Shares:
3658361(+0.0%)
Value:
$333.1B(-20.1%)
Allogene Therapeutics, Inc.
Shares:
22032040(+0.0%)
Value:
$32.2B(-31.4%)
Oric Pharmaceuticals, Inc.
Shares:
5376344(+0.0%)
Value:
$30.0B(-30.9%)
ARVINAS, INC.
Shares:
3457815(+0.0%)
Value:
$24.3B(-63.4%)
Tourmaline Bio, Inc.
Shares:
1272214(+0.0%)
Value:
$19.4B(-25.0%)
Wave Life Sciences Ltd.
Shares:
1875000(+0.0%)
Value:
$15.2B(-34.7%)
Biohaven Ltd.
Shares:
505645(+0.0%)
Value:
$12.2B(-35.6%)
Cardiff Oncology, Inc.
Shares:
2411575(+0.0%)
Value:
$7.6B(-27.6%)
Caribou Biosciences, Inc.
Shares:
4690431(+0.0%)
Value:
$4.3B(-42.6%)
Zura Bio Ltd
Shares:
2970022(+0.0%)
Value:
$3.8B(-48.4%)
Celcuity Inc.
Shares:
349406(+0.0%)
Value:
$3.5B(-22.8%)
ESSA Pharma Inc.
Shares:
1675000(+0.0%)
Value:
$2.6B(-11.7%)
Spero Therapeutics, Inc.
Shares:
2362348(+0.0%)
Value:
$1.7B(-30.1%)
Zentalis Pharmaceuticals, Inc.
Shares:
953834(+0.0%)
Value:
$1.5B(-47.5%)
Pyxis Oncology, Inc.
Shares:
1080507(+0.0%)
Value:
$1.1B(-37.2%)
AN2 Therapeutics, Inc.
Shares:
715295(+0.0%)
Value:
$972.8M(-1.4%)
NextCure, Inc.
Shares:
1573312(+29.7%)
Value:
$755.7M(-52.0%)
Q32 Bio Inc.
Shares:
277777(+0.0%)
Value:
$458.3M(-52.0%)
Bolt Biotherapeutics, Inc.
Shares:
626109(+0.0%)
Value:
$250.4M(-25.2%)
Senseonics Holdings, Inc.
Shares:
43426(+0.0%)
Value:
$28.5M(+25.4%)